BBPWM
ORGO icon

Blue Bell Private Wealth Management’s Organogenesis Holdings ORGO Stock Holding History

Blue Bell Private Wealth Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-200
Closed -$2K – 867
2022
Q1 		$2K Buy
200
+100
+100% +$774 ﹤0.01% 706
2021
Q4 		$1K Buy
+100
New +$1.06K ﹤0.01% 799

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blue Bell Private Wealth Management's ORGO Position: Q2 2022 in Review

Blue Bell Private Wealth Management sold out of Organogenesis Holdings (ORGO) in Q2 2022, closing a stake of 200 shares — an estimated $2K sold.

Blue Bell Private Wealth Management first reported a position in ORGO in Q4 2021 and held it in 2 quarters. The position peaked at $2K in Q1 2022. 146 funds tracked by Wall St. Rank hold ORGO as of Q2 2022.

  • Blue Bell Private Wealth Management reported no remaining Organogenesis Holdings position as of Q2 2022 after selling out during the quarter.
  • Blue Bell Private Wealth Management sold 200 Organogenesis Holdings shares in Q2 2022, an estimated $2K.
  • Blue Bell Private Wealth Management first reported a position in Organogenesis Holdings in Q4 2021 and held it in 2 quarters.
  • Blue Bell Private Wealth Management's Organogenesis Holdings position peaked at $2K in Q1 2022.
  • 146 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2022.

Based on Blue Bell Private Wealth Management's 13F filing for Q2 2022, filed 2 Aug 2022.